Results 141 to 150 of about 26,737 (201)

Host-directed treatments for tuberculous meningitis utilizing a multi-platform approach across mouse and human models. [PDF]

Nat Commun
Ruiz-Gonzalez CE, Singh M, Masias-Leon Y, Chen X, Sarhan MO, Martinez-Martinez YB, Patel S, Shambles M, Villabona-Rueda A, Lissit K, Tweedie D, Scerba MT, Bishai WR, Artemov D, Xu JC, D'Alessio F, Hafner R, Greig NH, Manion M, Sereti I, Jain SK.   +20 more
europepmc   +1 more source

Addition of Clofazimine Enhances the Activity of Standard Treatment Regimen in a Mouse Model of Tuberculous Meningitis. [PDF]

J Infect Dis
Chen X, Ruiz-Gonzalez CE, Masias-Leon Y, Singh M, Peloquin CA, Jain SK.   +5 more
europepmc   +1 more source

Hypothetical applications of MR-guided focused ultrasound in central nervous system tuberculosis: blood-brain barrier disruption, granulomatous lesion modulation, targeted drug delivery, and immune microenvironment reprogramming. [PDF]

Ann Med Surg (Lond)
Beniwal SS, Mwaanga C, Jassim M, Rawat A, Dahiya P, Ribeiro da Costa REA, Pandey A, Ali ASM, Moncada J, Mateen SSA, Mishra A.   +10 more
europepmc   +1 more source

Correction: Population pharmacokinetics model of pyrazinamide to optimize tuberculosis treatment: An interethnic cohort study of diabetes mellitus effect on drug exposure. [PDF]

PLoS One
Jayanti RP, Cho YS, Soedarsono S, Kim HJ, Kang J, Kim J, Oh JY, Kang BH, Ha JH, Kim JW, Mertaniasih NM, Kusmiati T, Permatasari A, Yuliwulandari R, Kim R, Seong HJ, Ghim JL, Kim DH, Shin JG, cPMTb.   +19 more
europepmc   +1 more source

Whole-genome sequencing guides the successful treatment of extensively drug-resistant TB. [PDF]

IJTLD Open
Makamure B, Phelan J, Bandason T, Chipinduro M, Mutsvangwa J, Metcalfe JZ, Fernandez FT, Manasa J.   +7 more
europepmc   +1 more source

Beyond the bladder: case series of <i>Mycobacterium bovis</i> bacillus Calmette-Guérin infections following intravesical instillation. [PDF]

ASM Case Rep
Workman AA, Parra O, Loeven NA, Kaur P, Schroeck FR, Seigne JD, Wang R, Martin IW.   +7 more
europepmc   +1 more source

Population pharmacokinetics of pyrazinamide and ethambutol in children with tuberculosis with or without HIV. [PDF]

Antimicrob Agents Chemother
Maranchick NF, Martyn-Dickens C, Enimil A, Yang H, Amissah AK, Dompreh A, Bosomtwe D, Sly-Moore E, Opoku T, Frimpong Appiah A, Asiedu P, Antwi S, Scheetz MH, Peloquin CA, Kwara A.   +14 more
europepmc   +1 more source

Rechallenge with First-Line Anti-Tubercular Therapy After Toxic Epidermal Necrolysis in an HIV-Positive Patient with Tubercular Pleural Effusion. [PDF]

Indian Dermatol Online J
Narula AS, Mathews J, Ashraf F, Khadanga S.   +3 more
europepmc   +1 more source

Predicting pyrazinamide resistance in Mycobacterium tuberculosis using a graph convolutional network. [PDF]

BMC Microbiol
Dissanayake D, Brunner V, Adlard D, Morrone JA, Fowler PW.   +4 more
europepmc   +1 more source

Rifampin as a novel trigger of drug-induced enterocolitis syndrome. [PDF]

IJTLD Open
Tamborino A, Liccioli G, Tomei L, Chiappini E, Trapani S, Mori F, Galli L, Venturini E.   +7 more
europepmc   +1 more source